Search research articles
Contact Us
Filters
Showing results (651-660 of 692) with videos related to
Page
of 70
Sort By:
Circulation. Cardiovascular Interventions
|
March 26, 2026
Five-Year Outcomes for Patients With RVOT Dysfunction Treated With the SAPIEN 3 Transcatheter Heart Valve: A Pooled Analysis From the COMPASSION S3 Trial
Michael R Hainstock, Gregory Fleming, Dennis Kim, et al.
European Urology Oncology
|
April 12, 2026
Extended Follow-up from the Stereotactic Body Radiotherapy for High-risk Localized Carcinoma of the Prostate (SHARP) Consortium: Updated Analysis of 440 Patients
Luca F Valle, Tahmineh Romero-Kalbasi, Tommy Jiang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 21, 2020
Phase 1 Trial of Stereotactic Body Radiation Therapy Neoadjuvant to Radical Prostatectomy for Patients With High-Risk Prostate Cancer
Neil R Parikh, Amar U Kishan, Nathanael Kane, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 6, 2019
Multi-Institutional Analysis of Prostate-Specific Antigen Kinetics After Stereotactic Body Radiation Therapy
Naomi Y Jiang, Audrey T Dang, Ye Yuan, et al.
JAMA Oncology
|
February 9, 2023
Hyaluronic Acid Spacer for Hypofractionated Prostate Radiation Therapy: A Randomized Clinical Trial
Neil F Mariados, Peter F Orio, Zvi Schiffman, et al.
Advances in Radiation Oncology
|
September 29, 2021
Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series
Jesus E Juarez, Tahmineh Romero, Constantine A Mantz, et al.
Prostate Cancer and Prostatic Diseases
|
July 11, 2020
The intraprostatic immune environment after stereotactic body radiotherapy is dominated by myeloid cells
Nicholas G Nickols, Ekambaram Ganapathy, Christine Nguyen, et al.
European Urology Oncology
|
February 19, 2021
Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging
Ting Martin Ma, Andrei Gafita, David Shabsovich, et al.
JAMA Network Open
|
December 17, 2025
Five-Day Preoperative Radiation Therapy for Patients With High-Risk Soft Tissue Sarcoma: A Nonrandomized Clinical Trial
John Nikitas, Joseph K Kendal, Ricky R Savjani, et al.
European Urology Oncology
|
June 20, 2025
Pooled Analysis of the SOLAR and SATURN Clinical Trials Comparing Progression of Synchronous Versus Metachronous Prostate-specific Membrane Antigen-defined Oligometastatic Prostate Cancer Following Systemic and Tumor-directed Therapy
Jesus E Juarez Casillas, John Nikitas, Matthew B Rettig, et al.
Page
of 70
Search research articles
Search
Showing results (651-660 of 692) with videos related to
Sort By:
Page
of 70
Circulation. Cardiovascular Interventions
|
March 26, 2026
Five-Year Outcomes for Patients With RVOT Dysfunction Treated With the SAPIEN 3 Transcatheter Heart Valve: A Pooled Analysis From the COMPASSION S3 Trial
Michael R Hainstock, Gregory Fleming, Dennis Kim, et al.
European Urology Oncology
|
April 12, 2026
Extended Follow-up from the Stereotactic Body Radiotherapy for High-risk Localized Carcinoma of the Prostate (SHARP) Consortium: Updated Analysis of 440 Patients
Luca F Valle, Tahmineh Romero-Kalbasi, Tommy Jiang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 21, 2020
Phase 1 Trial of Stereotactic Body Radiation Therapy Neoadjuvant to Radical Prostatectomy for Patients With High-Risk Prostate Cancer
Neil R Parikh, Amar U Kishan, Nathanael Kane, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 6, 2019
Multi-Institutional Analysis of Prostate-Specific Antigen Kinetics After Stereotactic Body Radiation Therapy
Naomi Y Jiang, Audrey T Dang, Ye Yuan, et al.
JAMA Oncology
|
February 9, 2023
Hyaluronic Acid Spacer for Hypofractionated Prostate Radiation Therapy: A Randomized Clinical Trial
Neil F Mariados, Peter F Orio, Zvi Schiffman, et al.
Advances in Radiation Oncology
|
September 29, 2021
Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series
Jesus E Juarez, Tahmineh Romero, Constantine A Mantz, et al.
Prostate Cancer and Prostatic Diseases
|
July 11, 2020
The intraprostatic immune environment after stereotactic body radiotherapy is dominated by myeloid cells
Nicholas G Nickols, Ekambaram Ganapathy, Christine Nguyen, et al.
European Urology Oncology
|
February 19, 2021
Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging
Ting Martin Ma, Andrei Gafita, David Shabsovich, et al.
JAMA Network Open
|
December 17, 2025
Five-Day Preoperative Radiation Therapy for Patients With High-Risk Soft Tissue Sarcoma: A Nonrandomized Clinical Trial
John Nikitas, Joseph K Kendal, Ricky R Savjani, et al.
European Urology Oncology
|
June 20, 2025
Pooled Analysis of the SOLAR and SATURN Clinical Trials Comparing Progression of Synchronous Versus Metachronous Prostate-specific Membrane Antigen-defined Oligometastatic Prostate Cancer Following Systemic and Tumor-directed Therapy
Jesus E Juarez Casillas, John Nikitas, Matthew B Rettig, et al.
Page
of 70